Table of Content

1 Study Coverage
1.1 OTC Drug Product Introduction
1.2 Market by Type
1.2.1 Global OTC Drug Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global OTC Drug Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global OTC Drug Market by Region
1.4.1 Global OTC Drug Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global OTC Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global OTC Drug Revenue by Players
2.1.1 Global OTC Drug Revenue by Players (2018-2023)
2.1.2 Global OTC Drug Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by OTC Drug Revenue in 2023
2.2 Global OTC Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global OTC Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Bayer HealthCare
3.1.1 Bayer HealthCare Information
3.1.2 Bayer HealthCare Overview
3.1.3 Bayer HealthCare OTC Drug Revenue and Gross Margin (2018-2023)
3.1.4 Bayer HealthCare Related Developments
3.2 GlaxoSmithKline(GSK)
3.2.1 GlaxoSmithKline(GSK) Information
3.2.2 GlaxoSmithKline(GSK) Overview
3.2.3 GlaxoSmithKline(GSK) OTC Drug Revenue and Gross Margin (2018-2023)
3.2.4 GlaxoSmithKline(GSK) Related Developments
3.3 Johnson&Johnson
3.3.1 Johnson&Johnson Information
3.3.2 Johnson&Johnson Overview
3.3.3 Johnson&Johnson OTC Drug Revenue and Gross Margin (2018-2023)
3.3.4 Johnson&Johnson Related Developments
3.4 Pfizer
3.4.1 Pfizer Information
3.4.2 Pfizer Overview
3.4.3 Pfizer OTC Drug Revenue and Gross Margin (2018-2023)
3.4.4 Pfizer Related Developments
3.5 Sanofi
3.5.1 Sanofi Information
3.5.2 Sanofi Overview
3.5.3 Sanofi OTC Drug Revenue and Gross Margin (2018-2023)
3.5.4 Sanofi Related Developments
3.6 AstraZeneca
3.6.1 AstraZeneca Information
3.6.2 AstraZeneca Overview
3.6.3 AstraZeneca OTC Drug Revenue and Gross Margin (2018-2023)
3.6.4 AstraZeneca Related Developments
3.7 BioGaia
3.7.1 BioGaia Information
3.7.2 BioGaia Overview
3.7.3 BioGaia OTC Drug Revenue and Gross Margin (2018-2023)
3.7.4 BioGaia Related Developments
3.8 Bristol Myers Squibb
3.8.1 Bristol Myers Squibb Information
3.8.2 Bristol Myers Squibb Overview
3.8.3 Bristol Myers Squibb OTC Drug Revenue and Gross Margin (2018-2023)
3.8.4 Bristol Myers Squibb Related Developments
3.9 Bukwang Pharmaceutica
3.9.1 Bukwang Pharmaceutica Information
3.9.2 Bukwang Pharmaceutica Overview
3.9.3 Bukwang Pharmaceutica OTC Drug Revenue and Gross Margin (2018-2023)
3.9.4 Bukwang Pharmaceutica Related Developments
3.10 Chr. Hansen
3.10.1 Chr. Hansen Information
3.10.2 Chr. Hansen Overview
3.10.3 Chr. Hansen OTC Drug Revenue and Gross Margin (2018-2023)
3.10.4 Chr. Hansen Related Developments
3.11 Cipla
3.11.1 Cipla Information
3.11.2 Cipla Overview
3.11.3 Cipla OTC Drug Revenue and Gross Margin (2018-2023)
3.11.4 Cipla Related Developments
3.12 CoLucid
3.12.1 CoLucid Information
3.12.2 CoLucid Overview
3.12.3 CoLucid OTC Drug Revenue and Gross Margin (2018-2023)
3.12.4 CoLucid Related Developments
3.13 Daiichi Sankyo
3.13.1 Daiichi Sankyo Information
3.13.2 Daiichi Sankyo Overview
3.13.3 Daiichi Sankyo OTC Drug Revenue and Gross Margin (2018-2023)
3.13.4 Daiichi Sankyo Related Developments
3.14 Friggs
3.14.1 Friggs Information
3.14.2 Friggs Overview
3.14.3 Friggs OTC Drug Revenue and Gross Margin (2018-2023)
3.14.4 Friggs Related Developments
3.15 DSM
3.15.1 DSM Information
3.15.2 DSM Overview
3.15.3 DSM OTC Drug Revenue and Gross Margin (2018-2023)
3.15.4 DSM Related Developments
3.16 Eisai
3.16.1 Eisai Information
3.16.2 Eisai Overview
3.16.3 Eisai OTC Drug Revenue and Gross Margin (2018-2023)
3.16.4 Eisai Related Developments
3.17 Eli Lilly
3.17.1 Eli Lilly Information
3.17.2 Eli Lilly Overview
3.17.3 Eli Lilly OTC Drug Revenue and Gross Margin (2018-2023)
3.17.4 Eli Lilly Related Developments
3.18 Herbalife
3.18.1 Herbalife Information
3.18.2 Herbalife Overview
3.18.3 Herbalife OTC Drug Revenue and Gross Margin (2018-2023)
3.18.4 Herbalife Related Developments
3.19 Euradite
3.19.1 Euradite Information
3.19.2 Euradite Overview
3.19.3 Euradite OTC Drug Revenue and Gross Margin (2018-2023)
3.19.4 Euradite Related Developments
4 Global OTC Drug Market Insights
4.1 Global OTC Drug Market Revenue 2018-2023
4.2 Global OTC Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global OTC Drug Revenue by Type
5.2 Global OTC Drug Market Size Growth by Type 2018-2023
6 Market Size by Application
6.1 Global OTC Drug Revenue by Application
6.2 Global OTC Drug Market Size Growth by Application 2018-2023
7 Americas
7.1 Americas OTC Drug Market Size by Type
7.1.1 Americas OTC Drug Revenue by Type (2018-2023)
7.1.2 Americas OTC Drug Revenue Share by Type (2018-2023)
7.2 Americas OTC Drug Market Size by Application
7.2.1 Americas OTC Drug Revenue by Application (2018-2023)
7.2.2 Americas OTC Drug Revenue Share by Application (2018-2023)
7.3 Americas OTC Drug Market Size by Country
7.3.1 Americas OTC Drug Revenue by Country (2018-2023)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe OTC Drug Market Size by Type
8.1.1 Europe OTC Drug Revenue by Type (2018-2023)
8.1.2 Europe OTC Drug Revenue Share by Type (2018-2023)
8.2 Europe OTC Drug Market Size by Application
8.2.1 Europe OTC Drug Revenue by Application (2018-2023)
8.2.2 Europe OTC Drug Revenue Share by Application (2018-2023)
8.3 Europe OTC Drug Market Size by Country
8.3.1 Europe OTC Drug Revenue by Country (2018-2023)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific OTC Drug Market Size by Type
9.1.1 Asia Pacific OTC Drug Revenue by Type (2018-2023)
9.1.2 Asia Pacific OTC Drug Revenue Share by Type (2018-2023)
9.2 Asia Pacific OTC Drug Market Size by Application
9.2.1 Asia Pacific OTC Drug Revenue by Application (2018-2023)
9.2.2 Asia Pacific OTC Drug Revenue Share by Application (2018-2023)
9.3 Asia Pacific OTC Drug Market Size by Region
9.3.1 Asia Pacific OTC Drug Revenue by Region (2018-2023)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa OTC Drug Market Size by Type
10.1.1 Middle East and Africa OTC Drug Revenue by Type (2018-2023)
10.1.2 Middle East and Africa OTC Drug Revenue Share by Type (2018-2023)
10.2 Middle East and Africa OTC Drug Market Size by Application
10.2.1 Middle East and Africa OTC Drug Revenue by Application (2018-2023)
10.2.2 Middle East and Africa OTC Drug Revenue Share by Application (2018-2023)
10.3 Middle East and Africa OTC Drug Market Size by Country
10.3.1 Middle East and Africa OTC Drug Revenue by Country (2018-2023)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 OTC Drug Industry Trends
11.2 OTC Drug Market Drivers
11.3 OTC Drug Market Challenges
11.4 OTC Drug Market Restraints
12 OTC Drug Forecasted Market Size by Type
12.1 Global OTC Drug Forecasted Revenue by Type
12.2 Global OTC Drug Forecasted Market Size Growth by Type 2023-2029
13 OTC Drug Forecasted Market Size by Application
13.1 Global OTC Drug Forecasted Revenue by Application
13.2 Global OTC Drug Forecasted Market Size Growth by Application 2023-2029
14 Global OTC Drug Market Forecasts
14.1 Global OTC Drug Market Revenue Forecasts 2023-2029
14.2 Global OTC Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas OTC Drug Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe OTC Drug Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific OTC Drug Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa OTC Drug Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer